Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C9OT
|
|||
Former ID |
DNC010580
|
|||
Drug Name |
N-(6-(trifluoromethyl)-1H-indazol-3-yl)butyramide
|
|||
Synonyms |
N-[6-(trifluoromethyl)-1H-indazol-3-yl]butanamide; CHEMBL1086640; 599191-49-8; N-(6-(trifluoromethyl)-1H-indazol-3-yl)butyramide; SCHEMBL1462440; RVYSDAGRNRYYML-UHFFFAOYSA-N
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H12F3N3O
|
|||
Canonical SMILES |
CCCC(=O)NC1=NNC2=C1C=CC(=C2)C(F)(F)F
|
|||
InChI |
1S/C12H12F3N3O/c1-2-3-10(19)16-11-8-5-4-7(12(13,14)15)6-9(8)17-18-11/h4-6H,2-3H2,1H3,(H2,16,17,18,19)
|
|||
InChIKey |
RVYSDAGRNRYYML-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1985-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.